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Explaining Hospital Length of Stay of Patients 
Admitted with Seasonal Influenza Infection 
 
Anna Lidofsky 
University of Vermont Department of Microbiology & Molecular Genetics 
201 Stafford Hall, 95 Carrigan Drive, Burlington, VT 05405 
One of the most common disease 
syndromes in humans are viral infections 
of the respiratory tract, and of these 
viruses, influenza viruses are one of the 
more significant causes of high morbidity 
and mortality.2, 3 Epidemics of influenza 
occur annually in the temperate zones 
during the winter months.2, 3   
Influenza viruses are segmented, negative-
sense, double-stranded RNA viruses.2 
Background: The annual occurrence of seasonal influenza virus poses a significant 
health burden worldwide.  There is evidence that certain populations are more at risk for 
influenza infection, such as cigarette smokers, the elderly, and patients with 
cardiopulmonary disorders.  In some cases influenza virus presents itself as a nosocomially 
acquired infection.  Thus, monitoring the length of time that patients are hospitalized with 
influenza is of clinical importance.1 The objectives of this study were to indentify 
predisposing characteristics to hospitalization with influenza and to determine whether 
cigarette smoking correlates to extended LOS (length of stay in hospital).  It was 
hypothesized that cigarette smoking and presence of COPD (Chronic Obstructive 
Pulmonary Disease) correlates most significantly to prolonged LOS. 
Methods: After ethical approval was achieved from the University of Vermont 
Institutional Review Board, information was collected from a retrospective cohort of adult 
patients admitted to FAHC (Fletcher Allen Health Care) with influenza infection during 
the 2012-2013 flu season.  Univariate analyses were performed to compare explanatory 
variables with LOS as an outcome.  A generalized linear model was constructed to further 
explain correlations with LOS. 
Results:  Among 54 patients, the median age was 73.5 and the median BMI (Body Mass 
Index) was 26.1 kg/m2.  The cohort was split almost equally between males and females 
and exactly two-thirds were smokers, with just under one-third of the patients diagnosed 
with COPD.  Univariate analyses determined that patients with COPD, diabetes, and 
more than one comorbid condition significantly increased LOS (p = 0.0129*, 0.0191*, 
0.0046*; respectively).  A generalized linear model revealed that patients with COPD and 
more than one comorbid condition were estimated have a significantly prolonged LOS (p 
= 0.0266* and 0.0079*, respectively).  Smoking status was not determined to be a 
significant explanatory variable in either set of analysis.  
Conclusions: Significant indicators for lengthier LOS are explained by diagnosis of 
COPD and patients with more than one comorbidity.  Promoting the use of vaccination 
for these at-risk individuals is imperative, as influenza infection is a serious issue.   
  2 
Some viral particles contain envelope 
proteins, which increase virulence through 
three transmembrane proteins: HA 
(hemagglutinin), NA (neuraminidase), and 
M2, an ion channel facilitator.  HA 
provides the receptor-binding site for 
viral-antibody neutralization, an essential 
function for virus infectivity.  Removal of 
sialic acid, the cell surface receptor for 
influenza, a process that is aided by NA, 
allows for release of viral particles from 
the cell surface and viral spread.  The ion 
channel is crucial during the uncoating 
process of the virus.2  
The arrangements of surface 
glycoproteins on HA and NA determine 
variable subtypes of influenza viruses.2 
Because influenza virus is segmented, 
many arrangements are possible and 
explains the continual appearance of new 
antigenic strains of influenza, as well as 
accounting for the occurrence of historical 
pandemics and yearly epidemics.2, 3 The 
evolution of new strains of viruses arises 
through antigenic drift and antigenic shift, 
which is characterized by point mutations 
in the surface glycoproteins of HA.2   
Influenza types A and B are the 
main human pathogens.2 Of the recently 
circulating influenza viruses, the H3N2 
strain of influenza A is the most virulent.2 
The aptitude of influenza virus to mutate 
explains its severe impact on humans in 
terms of morbidity and mortality, relative 
to respiratory viruses.2 
Influenza can cause a broad range 
of illness, ranging from symptomless 
infection to onset primary viral 
pneumonia and secondary bacterial 
pneumonia.2 In its full form, influenza is 
an acute respiratory disease characterized 
by high fever, cough, headache, and 
inflammation of the upper respiratory tree 
and trachea.  Symptoms typically persist 
for seven to ten days.3   
The severity of viral illness is highly 
dependent on the particular virus and host 
factors.  Much of the detrimental effects 
from influenza virus are concentrated in 
high-risk groups.  These include cigarette 
smokers, the elderly, and those with 
comorbid cardiovascular and pulmonary 
disease.2  
 
Cigarette Smoking: A Risk Factor for Influenza 
Infection 
 
According to researchers from the 
University of California San Francisco, 
infectious diseases could rival the usual 
suspects of sources of morbidity and 
mortality associated with smoking 
cigarettes, such as heart disease, cancer, 
and chronic lung disease.4 Indeed, there is 
increasing evidence that smokers are more 
susceptible to respiratory viral infections, 
although the mechanisms that mediate 
these effects are still being investigated. 
Cigarette smoke is a heterogeneous, 
complex mixture, containing over 4,700 
chemical compounds and oxidants.  These 
chemical agents induce an oxidative 
burden on the body, causing disruptions 
in normal mechanisms of cellular signaling 
that can lead to cellular damage of the 
lungs, specifically the alveolar wall, which 
leads to airway enlargement.5 
 Oxidative stress on the lungs can 
also result in loss of mucociliary function 
in the respiratory tract.  It is likely that this 
loss of function contributes to an increased 
risk of microbial infection in smokers by 
reducing the ability of the respiratory tract 
to clear pathogens.6 
A research team from the 
University of North Carolina Chapel 
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created an in vitro model of differentiated 
nasal epithelial cells from smokers (which 
emulates many characteristics of airway 
epithelium in vivo) in order to determine 
how the immune response elicited by 
epithelial cells contributes to the enhanced 
susceptibility of smokers. Results indicated 
that the immune response to influenza for 
smokers is significantly downregulated in 
comparison with nonsmokers.7   
These findings were confirmed in 
vivo, in a study in which human volunteers 
(smokers and non-smokers) were 
inoculated nasally with live-attenuated 
influenza virus vaccine.7   
One group of researchers looked to 
establish links between influenza virus and 
cigarette smoke using a mouse model.  
The team demonstrated the effects of 
cigarette smoke on alterations to innate 
immunity, specifically with PAMP- 
(pathogen-associated molecular pattern) 
induced pulmonary inflammation and 
remodeling in mice.8 It was demonstrated 
that cigarette smoke selectively enhances 
responses already induced in the murine 
lung by influenza virus and viral PAMPs, 
such as airway and alveolar inflammation 
and remodeling.8   
Importantly, it was shown that 
cigarette smoke and a synthetic analog of 
influenza virus interacted synergistically to 
enhance BAL (bronchoalveolar lavage) 
total cell recovery, airway, and alveolar 
inflammation.  BAL is a technique often 
used in immunological research as a way 
to sample components of the epithelial 
lining fluid and to determine pathogen 
levels in the lung.  It was also found that 
cigarette smoke selectively enhanced the 
ability of influenza analog to induce 
pulmonary emphysema and airway 
remodeling.8  
Other experiments by these 
researchers demonstrated that this 
synergism relies on a specific molecular 
pathway involving a mitochondrial 
antiviral signaling protein, cytokines, and 
an RNA-dependent protein kinase.  This 
pathway revealed that molecular facets of 
cigarette smoke could injure the lungs 
significantly enough to promote 
emphysema.8 The process of alveolar 
destruction is also thought to course with 
an imbalance between matrix protease 
and antiproteases, favoring the breakdown 
of extracellular matrix proteins.8, 9   
 
COPD Exacerbations and Viral Infection 
 
The leading cause of COPD 
(Chronic Obstructive Pulmonary Disease) 
is smoking cigarettes.  It is estimated that 
COPD affects 43 million people and is the 
fourth leading cause of morbidity and 
mortality in the United States.  By 2020, 
COPD is estimated to become the fifth 
leading cause of death worldwide.10  
 Acute exacerbations account for 
much of the morbidity and mortality 
associated with COPD, which result in 
patients having extreme difficulty in 
breathing.10 Infection of the 
tracheobronchial tree, the structure that 
forms the airways that supply air to the 
lungs, is the most common cause of 
COPD exacerbations.2 
A study was conducted among 
patients hospitalized with acute 
respiratory disease during an influenza 
epidemic, and it was determined that 
COPD was the most common underlying 
disease, suggesting that pulmonary disease 
is a significant risk factor for adverse 
outcome with influenza infection.11  
  4 
Direct studies of viral infections in 
COPD exacerbations suggest that there is 
an association of influenza with COPD.   
These studies have utilized modern 
diagnostic methods such as polymerase 
chain reaction (PCR) to detect virus-
associated exacerbations.12, 13,14  
The burden of COPD is 
proportionately greater in the elderly.2 A 
number of respiratory societies have 
published national or international 
guidelines for the optimal management of 
COPD, which generally recommend 
universal administration of annual 
influenza vaccination.10   It should be 
noted that there is evidence that 
vaccination is not necessarily effective at 
reducing hospitalization in patients with 
COPD, indicating that there could be a 
reduction in the efficacy of vaccination 
against influenza in patients diagnosed 
with COPD.15   
 
Prevalence of Smoking and COPD Among 
Vermonters 
 
A 2012 report conducted by the 
Behavioral Risk Factor Surveillance 
System of the Vermont Department of 
Health investigated the prevalence risk 
factors and behaviors throughout the 
state.  It was determined that 6% of 
Vermont adults have been diagnosed with 
COPD.16   
Adults 65 and older have 
significantly higher rates of COPD than 
all other age groups, suggesting that the 
prevalence of COPD increases as 
Vermonters age.16   
Only 17% of Vermonters reported 
being cigarette smokers in 2012, a value 
slightly lower than the national statistic of 
18.1% among U.S. adults being cigarette 
smokers.16, 17 Adults 65 and older smoke at 
significantly lower rates than those in 
other age groups.  Less than 62% of 
Vermont adult smokers made attempts to 
quit smoking in 2012, greater than the 
nationally reported value of 59% seen 
among all adults in the United States.  
Quit attempts are highest among the 18-
24 age group.16  This study did not report 
information about the specific smoking 
histories of adults over the age of 65.   
 
2012-2013 Influenza Season 
 
The 2012-2013 influenza season 
had an early start.  Influenza activity in 
the United States peaked four weeks 
earlier in comparison to recent seasons.  
This jump-started a strenuous year 
characterized by more infection than 
usual.18 
A striking outcome from the 2012-
2013 season was the ineffectiveness of a 
vaccine against strain A/H3N2 in the 
elderly population.  A study of vaccine 
inefficacy suggested that an antigenic shift 
could not sufficiently explain this 
observation, as the vaccine in younger 
populations was shown to elicit a normal 
immune response.19   
A proposed interpretation of this 
outcome is that elderly populations 
generate a narrow antibody response to 
the vaccine strain of H3N2, incapable of 
protecting against H3N2 virus with shifted 
antigenicity.19 Other studies show 
evidence of an increase in influenza-
attributable mortality rates among persons 
aged 65 years or older.20   
There is also an indication that 
older individuals who were vaccinated 
against influenza in 2012 were not 
necessarily fully protected. In an article 
  5 
published in the Morbidity and Mortality 
Weekly Report by the Centers for Disease 
Control, vaccine effectiveness was 
reported to be 32.0% in the age group of 
> 65 years, with 17.1% of this age group 
prevented against hospitalization with 
influenza due to the vaccine.21  
 
Objectives of Study 
 
Nosocomial infections are hospital-
acquired infections.  As influenza virus is 
considerably contagious through airborne 
transmission and has a better chance of 
infectivity due to its ability to easily 
mutate, it can present itself as a 
nosocomial infection.1, 2  
LOS (length of stay in hospital) 
measures the number of days that a 
patient will spend in the hospital.  Shorter 
lengths of stay indicate more efficient and 
effective care, and usually, a better 
outcome for the patient.22 Moreover, 
shorter lengths of stay reduce the spread of 
unwanted nosocomial infections, like 
influenza.  
This study is an epidemiological 
retrospective investigation seeking to 
determine which patient characteristics 
explained prolonged LOS, given 
admittance to hospital with influenza 
infection.  It was hypothesized that 
increased LOS due to influenza infection 
would significantly correlate with a 
patient’s smoking status and COPD 
condition.  
  
METHODS 
 
Study Area and Data Source 
 
PRISM, the hospital administrative 
database employed by FAHC (Fletcher 
Allen Health Care), was the source of data 
for this study.  FAHC serves a population of 
greater than 1 million individuals in 
Vermont and northern New York.23 The 
hospital is based in Burlington, Vermont 
and provides a full range of tertiary-level 
inpatient and outpatient services.   
 
Data Preparation, Collection, and Management  
 
Inclusion criteria were established 
to incorporate any patient at least 18 years 
old that was admitted for at least one night 
between October 1, 2012 and June 1, 
2013 with influenza infection as a primary 
reason for hospital admission, with 
confirmation from the Fletcher Allen 
Laboratory of presence of influenza viral 
infection.  After ethical approval was 
granted from the University of Vermont 
Institutional Review Board, the data set 
was accessed.  The following data was 
recorded into an Excel spreadsheet:  
• Age 
• Sex 
• Height 
• Weight 
• Viral strain 
• Current smoking status 
• Presence of smoking history  
• Presence of cardiac disease 
• Presence of kidney disease 
• Presence of cancer 
• Presence of diabetes 
• Presence of COPD 
All data was copied from Microsoft 
Excel into a spreadsheet for statistical 
analysis by JMP Pro version 10.0. 
Cardiac disease is a broad umbrella 
term with multiple definitions.24 For the 
purposes of this study, patients were 
defined as diagnosed with cardiac disease 
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if any of the following syndromes were 
included in their charts: 
• Coronary artery disease 
• Coronary atherosclerosis 
• Congestive heart failure 
• Primary hypertrophic 
cardiomyopathy 
• Non-ST elevation myocardial 
infarction  
• Acute coronary syndrome 
• Diastolic heart failure 
 All the explanatory variables are 
characteristics possessed by the patient 
prior to admission and did not change 
over the course of the hospital stay.  If 
patients died in hospital, they were 
excluded from analysis, as LOS no longer 
would adequately explain extent of 
morbidity from influenza infection. 
 
Outlier Analysis: LOS is “bedeviled by the 
presence of outliers” 26 
 
To calculate hospital LOS, the date 
the patient was initially admitted to 
FAHC was subtracted from the date the 
patient was discharged.  Outliers, 
normally those of unusually lengthy stays 
that are extremely variable in length and 
occurrence, often characterize the 
distribution of LOS in hospital, resulting 
in a skewed, non-normal distribution of 
LOS.25, 26   
The issue with incorporating 
outliers into analysis is the 
disproportionate effects they have when 
developing models for explaining LOS.  
Efforts have been made to develop 
accurate and consistent statistical methods 
for analyzing outliers of LOS distribution.  
Current recommendations suggest that 
exclusion of outliers be accomplished by 
defining the maximum cut-off point as the 
sum of the third quartile and the IQR 
(interquartile range) multiplied by 1.5.26  
Log transformation of data is also 
recommended, as it is known to generate a 
near normal distribution.26 A Kolmogrov-
Smirnov test was run after outlier analysis 
to assess the goodness of fit of LOS to a 
log-normal distribution.27 
 
Descriptive statistics 
  
 After outlier analysis, categorical 
and quantitative distributions were 
analyzed for 
• Age 
• Sex 
• Comorbidities 
• Viral strain 
• Smoking status 
• BMI (Body Mass Index categories 
shown in Table 1, page 12) 
• Date admitted 
• Hospital floor where the patient 
was initially admitted.   
Median and IQR were noted for 
continuous data, as distributions followed 
non-normal curves, and different 
proportions were noted for categorical 
data. 
 
Non-Parametric Univariate Statistical Analyses 
 
 Wilcoxon signed-rank tests were 
utilized as nonparametric significance tests 
to compare LOS to patient 
characteristics.27, 28 Because a leading 
cause of COPD is smoking, a Fisher’s 
exact probability test was performed to 
determine whether smoking status was 
independent of COPD status.28  
 
Choosing a Generalized Linear Model to Explain 
LOS 
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 It is argued that when modeling 
LOS the purpose of the analysis must be 
seriously considered.29 Indeed, “the 
significance of the association between 
length of stay and patient characteristics, 
as reported in the clinical literature, is due 
in part to the statistical model chosen.”29 
Because this study has a descriptive 
purpose, with an emphasis placed on 
explaining LOS as a result of patient 
characteristics, a generalized linear model 
was thus constructed to relate factors 
associated with patient LOS as the 
response variable.   
The number of days each patient 
stayed at the hospital is recorded as a 
count.30 As a consequence, the Poisson 
regression model is particularly 
appropriate when LOS is used as a 
response variable.30 A random variable 
will have Poisson distribution mean (µ) set 
equal to the variance of the distribution, 
meaning that any factor that affects one 
will also affect the other.31  
 A measure of discrepancy between 
observed and fitted values is the deviance.  
This deviance can be measured using 
Pearson’s chi-squared statistic in the same 
form as it would be used for binomial 
data.31    
 For this study, the most 
representative model was picked by 
confirmation of good fit.  The expected 
value of a chi-squared random variable is 
equal to its dF (degrees of freedom); 
meaning, the closer to 1 the ratio of the 
chi-squared expected value to dF is, the 
better the fit of the model.30 An additional 
fit statistic that was utilized was the fitted 
Akaike Information Criterion (AICc).  
The model with the lowest AICc value 
was chosen, as it is indicative of a good 
model.30  
 
RESULTS 
 
After reviewing the distribution of 
LOS, outliers were cut out as 
recommended by the literature.26 This 
resulted in outliers being defined as any 
patient staying 14 days or longer.   LOS 
data was log transformed after outlier 
analysis to assess the distribution’s 
normality, as shown in Figure 1 (page 13).  
The data did not follow a log normal 
distribution after outlier analysis, as the 
Kolmogrov-Smirnov test confirmed in 
Table 2 (page 14).  Descriptions of the six 
outliers are presented in Table 3 (page 15).   
 
Descriptive Statistical Analyses 
 
As Table 4 depicts (page 16), the 
most common comorbidity associated 
with the group is cardiac disease (n = 27; 
50.0%), followed by kidney disease (n = 
18, 33.3%), and equal prevalence of 
COPD and diabetes (n = 16, 29.6%).  
Cancer is only present in eight patients 
(14.8%).  Of the 54 patients included after 
outlier analysis, 48.1% of the patients have 
two or more of the observed comorbidities 
(n = 26).  
The distribution of sex is split 
almost equally, with 28 females and 26 
males.  As expected for a group of 
hospitalized adult patients infected with 
influenza in the 2012-2013 season, the 
cohort is predominately representative of 
an elderly population.30 Thus, the age 
distribution is skewed to the right, with a 
median age of 73.5.  The youngest patient 
is 36 years old and the oldest patient is 95 
years old.   
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The group is predominantly 
diagnosed with Seasonal H-3 Influenza A 
virus, with 64.8% of patients with cultures 
positive (n = 35).  22.2% of the group has 
Influenza A virus (n  = 12) and 13.0% of 
the group had Influenza B virus (n = 7). 
Information about height and 
weight was missing in the charts for two 
patients, but for the rest of the group, 
60.7% of the patients classify as either 
obese or overweight (n = 31), in 
accordance with BMI standards (Table 1, 
page 12).  38.4% of the group is classified 
with a normal BMI (n = 20), and only one 
patient is categorized as underweight.  
The median BMI is 26.1, overweight.  
Information about smoking histories was 
missing in the charts for three patients.  
Exactly two-thirds of the rest of the group 
were designated as smokers (n = 34, 
66.7%).  One-third of the patients were 
initially admitted to Baird 4, the Medicine 
unit of FAHC (n = 18, 33.3%).  The 
distribution of the months when patients 
first were admitted was also observed.  
Almost three-quarters of the patients were 
admitted in January (n = 28, 51.9%) or 
December (n = 11, 20.3%).  
 
Univariate Analyses 
 
 Wilcoxon tests were performed for 
linear regression and one-way ANOVA 
univarate analyses, comparing one patient 
characteristic as an explanatory variable 
to LOS as the response variable.  Table 5 
(page 17) displays explanatory variables 
that significantly explained longer LOS.  
These included diabetes, COPD and 
having two or more comorbidities  (p = 
0.0191*, 0.0129*, and 0.0046*; 
respectively).   Smoking did not 
significantly explain longer LOS.   
 Extent of comorbidities was coded 
as “A” (presence of 1 or 0 comorbid 
conditions) or “B” (presence of 2-5 
comorbid conditions).  
 It was also determined that the 
probability of being a smoker was 
significantly greater for patients diagnosed 
with COPD (p = 0.0047*), according to a 
Fisher’s Exact test as displayed in Table 6 
(page 18). 
 
Generalized Linear Model: COPD and Extent of 
Comorbidities Significantly Explain LOS 
 
 50 patients were included in the 
construction of a generalized linear model 
fit, which was generated to determine 
what factors influencing LOS due to 
influenza infection could be deemed as 
independent explanations.  Factors that 
were included in the model were standard 
demographic information (Age, Sex, 
BMI), smoking status, cardiac disease, 
diabetes, COPD, and extent of 
comorbidities (A or B). 
 Table 7 (page 19) displays multiple 
tests for goodness of fit, including Pearson 
and Deviance chi-square to dF ratios, and 
AICc values.  
  Finally, Table 8  (page 20) 
summarizes the parameter estimates from 
the generalized linear model.  Patients 
without COPD and 1 or less comorbidities 
were estimated to significantly stay less (p 
= 0.0266* and 0.0079*, respectively).  
Smoking status, however, was not a 
significant explanatory value.  
 
DISCUSSION 
 
Significance of COPD and Extensiveness of 
Comorbidities: Why not Smoking Status? 
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 The major findings of this study 
imply that COPD and patients with 
extensive comorbid conditions that are 
admitted to the hospital for influenza are 
estimated to stay longer in the hospital.  
These results are in accordance with 
clinical wisdom, considering that LOS is 
to an extent a measure of burden of 
disease.22    
  However, part of the initial 
hypothesis cannot be fully confirmed, 
which was the idea that smoking status 
would indirectly correlate with prolonged 
LOS.  The underlying basis for the 
proposed hypothesis was the plethora of 
literature discussing the synergistic effects 
of cigarette smoking and viral infection, 
specifically influenza.4-9, 32 Yet univariate 
and multivariate analysis with smoking 
status as an explanatory variable did not 
significantly explain longer stays in 
hospital.  There are two possible 
explanations why the hypothesis was not 
confirmed.    
First, smoking status was defined in 
a broad sense.  Smokers were designated 
as any patients with any form of smoking 
history (including new smokers, light 
smokers, heavy smokers, current non-
smokers with history of smoking).  Ideally, 
patients would have been categorized into 
different levels of smoking status, but 
unfortunately, there was not enough 
information about pack-years in the 
patient charts to determine extent of 
smoking history.  It is suggested in the 
literature that repeated use of cigarettes 
could lead to worsened susceptibility to 
influenza infection, relative to lighter 
exposure to cigarette smoke.32 This 
finding implies that patients who have a 
heavier smoking history could be more 
susceptible to lengthier stays in hospital.  
Moreover, one study determined that after 
six weeks of smoking cessation, patients 
regained significant functionalities in 
adaptive immune response.32 The general 
way in which smoking status was assigned 
for this study was unlikely able to account 
for these variables.   
Given the significant correlation of 
COPD to smoking status (Table 6, page 
18), COPD could be considered a marker 
of the burden of heavy smoking.  And as 
shown in Table 4 (page 16) a majority of 
the subjects designated as smokers in the 
study did not have COPD (55.9%), 
indicating that there might have been a 
wide range of levels of smoking usage in 
subjects designated as smokers. This 
implies that specifically heavy smoking, 
not just any general exposure to smoking, 
could be associated with prolonged LOS. 
A second possible reason 
explaining why smoking status did not 
associate with extended LOS is that 
models were too underpowered to 
adequately address the issue of smoking.  
As depicted in Table 4 (page 16), a 
majority of the cohort were smokers 
(66.7%, n = 34).  The sample size of non-
smokers was consequently rather small, 
resulting in a plausible power issue in the 
model.   
 
Cardiac Disease: An Anomaly in the Model  
 
In the generalized linear model, 
absence of cardiac disease was almost 
significant as an explanatory factor of 
increased LOS due to flu infection (p = 
0.0562).  This finding is peculiar because 
cardiac diseases are associated among risk 
factors for influenza infection.2 A potential 
explanation for this outcome could be that 
preferential treatment is given to patients 
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with cardiac conditions by clinicians.  
However, there is no evidence to support 
this speculation in the literature, so this 
result is puzzling. 
 
Modeling Bias and Other Limitations 
  
Identifying the causes of a health 
outcome, such as LOS in an uncontrolled 
environment, is problematic because of 
the high prevalence of modeling bias.33   
Model overfit, or more commonly, 
underfit, can lead to severely invalid 
conclusions due to confounding between 
relevant covariates or between covariates 
and casual variables.33 A plethora of 
potential significant explanatory values 
that were not included in this study may 
better explain extended LOS due to 
infection with influenza. 
In retrospective studies such as this 
one, correlation does not imply causation. 
Ideally, it is recommended that future 
controlled experiments be conducted to 
confirm suspicions of COPD and 
extensive comorbidities by establishing 
causal relationships between explanatory 
variables and the health end point, LOS.33 
In the context of this study, however, 
controlled experiments explaining LOS 
due to influenza infection may be difficult 
to construct. 
Additionally, to reduce potential 
confounding between comorbidities, it is 
suggested in the literature to utilize 
comorbidity scores as a way to rank the 
severity of additional complications.34 
Further studies could also try to account 
for the patients with cardiac disease, 
perhaps categorizing different cardiac 
disease syndromes and ranking them, as 
this was an unusual finding from the linear 
model. 
A further limitation of this study is 
that COPD is commonly misdiagnosed.35 
A final thought worth mentioning is that, 
given the high prevalence of elderly 
patients in the cohort’s age distribution, 
this investigation can be considered a 
geriatric study of sorts.  There is a 
potential for a multitude of external biases, 
such as frailty, which is a significantly 
weakened state due to the cumulative 
decline over an individual’s lifetime of 
multiple physiological systems.36  
  
CONCLUSIONS 
 
It is an important finding that LOS 
of patients hospitalized with influenza is 
estimated to be lengthier in patients with 
COPD and multiple comorbid conditions.  
Targeting these high-risk individuals for 
vaccination may reduce the burden of 
hospitalization and nosocomial risk.  
Indeed, these findings support current 
recommendations for emphasis of 
populations that should be vaccinated.37  
 Insufficient evidence of vaccination 
in the charts excluded the possibility of 
accounting for vaccination histories of 
subjects.  It could be that there is a limited 
adherence to vaccine standards in 
Vermont and northern New York, 
especially for at-risk populations.  Further 
studies are necessary to validate this 
speculation.   
 With a burdensome infectious 
disease such as influenza, it is imperative 
to construct measures to reduce LOS to a 
minimum.  The benefits include reduced 
costs, enhance quality of life for patients, 
an improvement in the utilization of 
resources and a reduction in the risk of 
viral transmission to other patients in the 
hospital.  
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ABBREVIATIONS 
 
 
 
 
 
 
AICc Akaike Information Criteria 
Value 
 
BMI Body Mass Index 
 
BAL  Broncholavear lavage 
 
COPD Chronic Obstructive 
Pulmonary Disease 
 
dF Degrees of freedom  
 
FAHC Fletcher Allen Health Care 
 
HA Hemagglutinin 
 
IQR Interquartile Range 
 
LOS Length of Stay 
 
NA Neuraminidase 
 
PAMP Pathogen-associated 
molecular pattern 
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Table 1 
Body Mass Index Classifications 
 
Category BMI (kg/m2) 
 
Underweight 
 
<18.5 
 
Normal 18.5-24.9 
 
Overweight 25.0-29.9 
 
Obesity, Class I 30.0-34.9  
 
Obesity, Class II 35.0-39.9 
 
Extreme Obesity, Class III > 40 
Note.  Adapted from “Preventing and Managing the 
Global Epidemic of Obesity. Report of the World 
Health Organization Consultation of Obesity.” 
WHO, Geneva, June 1997.26 
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Figure 1 
 
 
 
 
 
 
 
 
 
Days 
Note.  LOS Distribution, fitted log-normal.  
0 1 2 3 4 5 6 7 8 9 10 12 14
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Table 2 
Kolomogorov-Smirnov Goodness of Fit 
Test Statistic (D) P 
0.1349 0.0211* 
Note.  Null hypothesis = the data is from Log 
Normal distribution.  Small p-values reject null 
hypothesis.  α = 0.05. Significant at P  < 0.05. 
  15 
Table 3 
Profiles of the Outliers 
 
Patient Identification LOS Comments 
 
V06 
 
 
 
20 days 
 
73-year-old female, non-
smoker with cardiac disease, 
COPD, and diabetes 
 
V07 
 
65 days 67-year-old borderline 
overweight male, former 
smoker (105 pack years), 
cardiac disease and diabetes 
 
V11 
 
19 days 64-year-old overweight male, 
former smoker (168 pack 
years), cardiac disease and 
COPD 
 
V12 
 
14 days 59-year-old male, former 
smoker (60 pack years), 
COPD 
 
V25 
 
14 days 97-year-old female, non-
smoker with cardiac disease 
 
V64 21 days 57-year-old female, former 
smoker (3 pack years), 
kidney disease and diabetes 
Note.  Six outliers were excluded from the study. 
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Table 4 
General Characteristics of Patient Cohort 
 
Demographic n (%) Demographic 
 
n (%) 
Gender 
Female 
 
 
28 (51.9) 
Smoking Status* 
Smoker 
COPD in Smokers 
 
 
34 (66.7) 
15 (44.1) 
BMI Category* 
Underweight 
Normal 
Overweight 
Obesity, Class I 
Obesity, Class II 
Obesity, Class III 
 
1 (1.9) 
20 (38.4) 
16 (30.8) 
4 (7.7) 
4 (7.7) 
7 (13.5) 
Month Admitted  
December 
January  
February 
March  
April 
May 
 
 
11 (20.3) 
28 (51.9) 
9 (16.7) 
1 (1.9) 
3 (5.5) 
2 (3.7) 
Viral Strain 
A 
B 
Seasonal H3A 
 
 
12 (22.2) 
7 (13.0) 
35 (64.8) 
Floor Initially Admitted To 
Medicine 
Cardiology 
Orthopedics 
Cardiothoracic 
Medical ICU 
 
18 (33.3) 
11 (20.3) 
7 (13.0) 
7 (13.0) 
4 (7.4) 
Comorbidities 
Cardiac Disease 
Kidney Disease 
COPD 
Diabetes 
Cancer 
> 2 of the above 
 
 
27 (50.0) 
18 (33.3) 
16 (29.6) 
16 (29.6) 
8 (14.8) 
26 (48.1) 
Neurology 
General Surgery 
Surgical ICU 
Emergency 
3 (5.5) 
2 (3.7) 
1 (1.9) 
1 (1.9) 
Demographic  
 
Age 
 
BMI* 
 
LOS 
Median (IQR) 
 
73.5 (20.5) 
 
26.1 (8.3) 
 
4 (4.0) 
  
Note. * = Total n ≠54 for these patients; information missing from charts 
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Table 5 
Indicators of Significant Extension of LOS 
Explanatory 
Variable 
ChiSquare  dF P 
Diabetes 5.4927 1 0.0191* 
COPD 6.1888 1 0.0129* 
>2 Comorbidities  8.0387 1 0.0046* 
Note.  Univariate analyses conducted at α = 
0.05. Significant at P  < 0.05. Wilcoxon; 
Pearson’s ChiSquare Test. 
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Table 6 
Fisher’s Exact Test 
Test P Alternative Hypothesis 
Left 0.9997 P (Smoking Status = 
Smoker) is greater for 
absence of COPD 
 
Right 0.0047* P (Smoking Status = 
Smoker) is greater for 
presence of COPD 
 
2-Tail 0.0089* P (Smoking Status = 
Smoker) is different 
across COPD 
Note.  n = 51, α = 0.05 
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Table 7 
Goodness of Fit 
  
Fit Statistic ChiSquare dF ChiSq:dF ratio    P  
 
Pearson 
 
 
52.9536 
 
41 
 
     1.2916 
 
0.0999 
Deviance 
 
48.4508 41      1.1817 0.1976 
 AICc     
236.15        
Note. The closer the ChiSquare:dF ratio is to 1, the better 
the fit.  Smaller AICc indicates a better fit30  
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Table 8 
Parameter Estimates from Generalized Linear Model 
Term Estimate Std Error dF ChiSquare P Confidence Interval 
 
Intercept 
 
 
1.5875 
 
0.5054 
 
1 
 
9.4329 
 
0.0021* 
 
0.5831 to 2.5661 
Age -4.1e-6 0.0052 1 6.41e-7 0.9994 -0.010 to 0.0102 
Female 
 
0.0535 0.0729 1 0.5388 0.4629 -0.0894 to 0.1965 
BMI 
 
0.0005 0.0090 1 0.0029 0.9567 -0.0174 to 0.0179 
Non-smoker 
 
-0.0188 0.0883 1 0.0456 0.8310 -0.1940 to 0.1528 
Absence of 
Cardiac 
Disease 
 
0.1538 0.0803 1 3.6458 0.0562 -0.0041 to 0.3109 
Absence of 
Diabetes  
 
-0.0742 0.0780 1 0.9053 0.3414 -0.2268 to 0.0789 
Absence of 
COPD 
 
-0.1693 0.0760 1 4.9163 0.0266* -0.3181 to -0.0198 
<1 
Comorbidity 
 
-0.2416 0.0906 1 7.0593 0.0079* -0.4193 to -0.0636 
Note.  n =50,  α = 0.05, Generalized linear model, log-link function with Poisson 
distribution.  
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